wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34687225-09CC0295-FAE3-4066-BE39-6BFC4E863675
Q34687225-09CC0295-FAE3-4066-BE39-6BFC4E863675
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34687225-09CC0295-FAE3-4066-BE39-6BFC4E863675
A phase I study of continuous infusion cilengitide in patients with solid tumors.
P2860
Q34687225-09CC0295-FAE3-4066-BE39-6BFC4E863675
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34687225-09CC0295-FAE3-4066-BE39-6BFC4E863675
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d9270fe32469e6906af2a57cb18dfa2fbcb513f
P2860
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.